Common Stock |
2.64M |
$13.2M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund III QP, LP |
|
|
Common Stock |
1.02M |
$5.12M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund II QP, LP |
|
|
Common Stock |
799K |
$4M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund I, LP |
|
|
Common Stock |
468K |
$2.34M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund I QP, LP |
|
|
Common Stock |
436K |
$2.18M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Azitra Co-Invest I, LP |
|
|
Common Stock |
427K |
$2.13M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund III NT, LP |
|
|
Common Stock |
405K |
$2.02M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund III, LP |
|
|
Common Stock |
313K |
$1.57M |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund II, LP |
|
|
Common Stock |
137K |
$685K |
$5.00 |
Jun 21, 2023 |
Directly held by Bios Fund II NT, LP |
|
|
Common Stock |
91K |
$455K |
$5.00 |
Jun 21, 2023 |
Directly held by Circle K Invesco, LP |
|
|
Convertible Notes |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund III, LP |
|
|
Convertible Notes |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund III NT, LP |
|
|
Convertible Notes |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund III QP, LP |
|
|
Series A-1 Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Azitra Co-Invest I, LP |
Common Stock |
|
Series A-1 Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund II, LP |
Common Stock |
|
Series A-1 Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund II NT, LP |
Common Stock |
|
Series A-1 Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund II QP, LP |
Common Stock |
|
Series A Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund I, LP |
Common Stock |
|
Series A Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund I QP, LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund III, LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund III NT, LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund III QP, LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund II, LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund II NT, LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Jun 21, 2023 |
Directly held by Bios Fund II QP, LP |
Common Stock |
|